A Multicenter Study To Evaluate Ceftaroline Breakpoints: Performance in an Area with High Prevalence of Methicillin-Resistant Staphylococcus aureus Sequence Type 5 Lineage.

MLA

Khan, Ayesha, et al. “A Multicenter Study To Evaluate Ceftaroline Breakpoints: Performance in an Area with High Prevalence of Methicillin-Resistant Staphylococcus Aureus Sequence Type 5 Lineage.” Journal of Clinical Microbiology, vol. 57, no. 9, Aug. 2019. EBSCOhost, https://doi.org/10.1128/JCM.00798-19.

APA

Khan, A., Rivas, L. M., Spencer, M., Martinez, R., Lam, M., Rojas, P., Porte, L., Silva, F., Braun, S., Valdivieso, F., Mv Lhauser, M., Lafourcade, M., Miller, W. R., García, P., Arias, C. A., & Munita, J. M. (2019). A Multicenter Study To Evaluate Ceftaroline Breakpoints: Performance in an Area with High Prevalence of Methicillin-Resistant Staphylococcus aureus Sequence Type 5 Lineage. Journal of Clinical Microbiology, 57(9). https://doi.org/10.1128/JCM.00798-19

Chicago

Khan, Ayesha, Lina M Rivas, Maria Spencer, Rodrigo Martinez, Marusella Lam, Pamela Rojas, Lorena Porte, et al. 2019. “A Multicenter Study To Evaluate Ceftaroline Breakpoints: Performance in an Area with High Prevalence of Methicillin-Resistant Staphylococcus Aureus Sequence Type 5 Lineage.” Journal of Clinical Microbiology 57 (9). doi:10.1128/JCM.00798-19.